Login

Willkomen zurück, bitte gebe deine Zugangsdaten ein!

Passwort vergessen

Anmeldung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Accelerating the Translation of Cell Therapy for Type 1 Diabetes - 2026 - NIDDK

This public workshop will be held to discuss best practices and recommendations to foster the translation of the next generation of cell replacement therapies for type 1diabetes (T1D).

Veranstaltungen

Bild der Veranstaltung
22.09.2026 13:00 - 23.09.2026 21:00

Accelerating the Translation of Cell Therapy for Type 1 Diabetes

See Important Visitor Information below regarding an earlier registration deadline for foreign visitors. Purpose This public workshop aims to bring together relevant stakeholders to discuss best pract...
The Lister Hill Center (Building 38A)
20894 Bethesda

Ähnliche Seiten

https://www.manilatimes.net/2026/04/14/tmt-newswire/globenewswire/sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451/2319392

Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 | The Manila Times

https://www.manilatimes.net/2026/04/14/tmt-newswire/globenewswire/sana-biotechnology-and-mayo-clinic-announce-strategic-collaboration-focused-on-improving-care-in-type-1-diabetes-and-accelerating-development-of-sc451/2319392
https://www.cdc.gov/diabetes/diabetes-testing/screening-type-1-diabetes.html

Screening for Type 1 Diabetes | Diabetes | CDC

https://www.cdc.gov/diabetes/diabetes-testing/screening-type-1-diabetes.html
https://idw-online.de/de/news866153

From Theory to Practice: Supporting the Next Generation of Projects in Gene- and Cell-Based Therapies Across Germany

https://idw-online.de/de/news866153
https://newsroom.ucla.edu/releases/gene-therapy-research-sickle-cell-disease-taught-ucla-scientists

What a decade of gene therapy research for sickle cell disease taught UCLA scientists | UCLA

https://newsroom.ucla.edu/releases/gene-therapy-research-sickle-cell-disease-taught-ucla-scientists
https://www.manilatimes.net/2026/02/20/tmt-newswire/globenewswire/senti-bio-participates-in-cell-gene-live-event-highlighting-cutting-edge-technologies-advancing-cell-therapy-development/2281976

Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development | The Manila Times

https://www.manilatimes.net/2026/02/20/tmt-newswire/globenewswire/senti-bio-participates-in-cell-gene-live-event-highlighting-cutting-edge-technologies-advancing-cell-therapy-development/2281976
https://www.manilatimes.net/2026/04/23/tmt-newswire/globenewswire/novo-nordisks-oral-semaglutide-demonstrates-potential-to-be-the-first-oral-glp-1-ra-therapy-for-children-and-adolescents-with-type-2-diabetes/2326833

Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes | The Manila Times

https://www.manilatimes.net/2026/04/23/tmt-newswire/globenewswire/novo-nordisks-oral-semaglutide-demonstrates-potential-to-be-the-first-oral-glp-1-ra-therapy-for-children-and-adolescents-with-type-2-diabetes/2326833